Metabolic Syndrome and Body Composition Among People Aged 50 Years and Over: Results from The Neyshabur Longitudinal Study on Ageing (NeLSA)

2021 ◽  
Author(s):  
Mohsen Azimi-Nezhad ◽  
Nayyereh Aminisani ◽  
Ahmad Ghasemi ◽  
Azam Rezaei Farimani ◽  
Fatemeh Khorashadizadeh ◽  
...  
Keyword(s):  
Metabolic Syndrome ◽  
Body Composition ◽  
Longitudinal Study

Body composition and concentration of 25-OH vitamin D as metabolic syndrome indicators in patients with non-functioning adrenal incidentalomas

2018 ◽  
Author(s):  
Joanna Kowalska ◽  
Iwona Zielen-Zynek ◽  
Justyna Nowak ◽  
Karolina Kulik-Kupka ◽  
Agnieszka Bedkowska-Szczepanska ◽  
...  
Keyword(s):  
Metabolic Syndrome ◽  
Vitamin D ◽  
Body Composition ◽  
Adrenal Incidentalomas ◽  
25 Oh Vitamin D

scholarly journals A longitudinal study over 40 years to study the metabolic syndrome as a risk factor for cardiovascular diseases

2021 ◽  
Vol 11 (1) ◽  
Author(s):  
Lars Lind ◽  
Johan Sundström ◽  
Johan Ärnlöv ◽  
Ulf Risérus ◽  
Erik Lampa
Keyword(s):  
Metabolic Syndrome ◽  
Risk Factor ◽  
Longitudinal Study ◽  
Clinical Intervention ◽  
The Elderly ◽  
Adult Men ◽  
The Metabolic Syndrome ◽  
The Impact ◽  
Over 40 Years

AbstractThe impact of most, but not all, cardiovascular risk factors decline by age. We investigated how the metabolic syndrome (MetS) was related to cardiovascular disease (CVD) during 40 years follow-up in the Uppsala Longitudinal Study of Adult Men (ULSAM, 2,123 men all aged 50 at baseline with reinvestigations at age 60, 70, 77 and 82). The strength of MetS as a risk factor of incident combined end-point of three outcomes (CVD) declined with ageing, as well as for myocardial infarction, ischemic stroke and heart failure when analysed separately. For CVD, the risk ratio declined from 2.77 (95% CI 1.90–4.05) at age 50 to 1.30 (95% CI 1.05–1.60) at age 82. In conclusion, the strength of MetS as a risk factor of incident CVD declined with age. Since MetS was significantly related to incident CVD also at old age, our findings suggest that the occurrence of MetS in the elderly should not be regarded as innocent. However, since our data were derived in an observational study, any impact of MetS in the elderly needs to be verified in a randomized clinical intervention trial.

Sign in / Sign up

Export Citation Format

Share Document